van Hilst, Jony https://orcid.org/0000-0003-4990-445X
Korrel, Maarten
Lof, Sanne
de Rooij, Thijs
Vissers, Frederique
Al-Sarireh, Bilal
Alseidi, Adnan
Bateman, Adrian C.
Björnsson, Bergthor
Boggi, Ugo
Bratlie, Svein Olav
Busch, Olivier
Butturini, Giovanni
Casadei, Riccardo
Dijk, Frederike
Dokmak, Safi
Edwin, Bjorn
van Eijck, Casper
Esposito, Alessandro
Fabre, Jean-Michel
Falconi, Massimo
Ferrari, Giovanni
Fuks, David
Groot Koerkamp, Bas
Hackert, Thilo
Keck, Tobias
Khatkov, Igor
de Kleine, Ruben
Kokkola, Arto
Kooby, David A.
Lips, Daan
Luyer, Misha
Marudanayagam, Ravi
Menon, Krishna
Molenaar, Quintus
de Pastena, Matteo
Pietrabissa, Andrea
Rajak, Rushda
Rosso, Edoardo
Sanchez Velazquez, Patricia
Saint Marc, Olivier
Shah, Mihir
Soonawalla, Zahir
Tomazic, Ales
Verbeke, Caroline
Verheij, Joanne
White, Steven
Wilmink, Hanneke W.
Zerbi, Alessandro
Dijkgraaf, Marcel G.
Besselink, Marc G.
Abu Hilal, Mohammad
,
Funding for this research was provided by:
Covidien (ISR-2017-10928)
Article History
Received: 12 April 2021
Accepted: 3 August 2021
First Online: 9 September 2021
Declarations
:
: The medical ethics review committee of the Amsterdam UMC, location Academic Medical Center (Amsterdam, the Netherlands) has approved the trial protocol (NL63299.018.17). The trial is registered with the identification number ISRCTN44897265. Registration was prospective on 16-04-2018: . Patients can only participate if written informed consent has been provided.
: Not applicable.
: The authors declare that they have no competing interests.